Programming by Estrogen Treatment in Gonadotropin Releasing Hormone Antagonist Protocol

• Register: ClinicalTrials.gov
• Last refreshed on: 19 February 2015
• Main ID: NCT01419353
• Date of registration: 01/08/2011
• Prospective Registration: Yes
• Primary sponsor: Meir Medical Center
• Public title: Programming by Estrogen Treatment in Gonadotropin Releasing Hormone Antagonist Protocol
• Scientific title: Programming by Estrogen Treatment in Gonadotropin Releasing Hormone Antagonist Protocol
• Date of first enrolment: August 2011
• Target sample size: 63
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT01419353
• Study type: Interventional
• Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
• Phase: Phase 4

Countries of recruitment

Israel

Contacts

• Name: Adrian Shulman, MD
• Affiliation: Meir Medical Center

Key inclusion & exclusion criteria

Inclusion Criteria:

- IVF treatment in the following indications: Male, Mechanical, Unexplained

- Age<38 years

- Treatment Cycle number 1-4

Exclusion Criteria:

- Ovulatory disorder as an indication for IVF

- Repeated failure in previous IVF treatments (> than 4 cycles)

- Sperm used for treatment was retrieved by surgical procedure



Age minimum: N/A
Age maximum: 38 Years
Gender: Female

Health Condition(s) or Problem(s) studied

Infertility

Intervention(s)

Drug: estradiol valerate

Primary Outcome(s)

ovum pickup rate that took place between Sunday to Thursday without a compromise [Time Frame: a year]

Secondary Outcome(s)

pregnancy rate [Time Frame: a year]

Secondary ID(s)

Antagonist_prog

Source(s) of Monetary Support

Please refer to primary and secondary sponsors